TERT and MYC, for example, have been linked to enhanced drug sensitivity of cancer cells to nelarabine, palbociclib, hydroxyurea, cytarabine, fluphenazine, fludarabine, carmustine, and other drugs. The gene discussed is MYC; the disease is cancer.